Objectives: Clinical trial registration is widely recommended, since it allows tracking of trials that helps ensure full and unbiased reporting of their results. Aim of the present overview was to provide empirical evidence on bias associated with trial registration via a meta-epidemiological approach.
Randomized clinical trials are regarded as the gold standard in comparative efficacy research and form the basis for translating research evidence to clinical practice [1] . Among their advantages, methodological transparency is crucial and entails registration of the trial design protocol in a public domain prior to trial initiation in order to improve accountability in the conduct and reporting of research [2] . Trial protocols can be used post hoc to compare the original plan with subsequent procedures and analyses [3] , thereby potentially reducing the risk of data dredging. A priori trial registration can additionally safeguard against bias-related phenomena such as delayed publication or non-publication of trials, selective reporting of outcomes, manipulation of the analysis plan, and counting covert duplicate publications within systematic reviews as separate trials [3] [4] [5] [6] .
Insights on trial characteristics systematically associated with treatment effects can be gleamed through meta-epidemiological studies. This is a subgenre of the big family of overviews of reviews, wherein data from a collection of meta-analyses is integrated and classified according to a specific studylevel trait in order to empirically assess its influence on treatment effects [7] .
A recent comprehensive meta-epidemiological study reported that non-registered or retrospectively registered trials tend to show larger treatment effects [8] . Although the effect was not statistically significant, this is confirmed by cross-sectional overviews of randomized trials in cardiology [9] or general medicine [10] that report weak associations between positive findings and trial registration, although the effects were not always consistent. It is also important to note that these analyses were based on qualitative evaluations of trial results by using either a P value cut-off or the trialists' interpretation of the results in text, both of which can be problematic.
Scope
The aim of this meta-epidemiological study is to provide empirical evidence of possible differences in the results of registered and non-registered randomized clinical trials in orthodontics as a sign of bias, including its direction and magnitude. 
Methods

Protocol, eligibility criteria, and registration
The protocol for this overview of reviews and trials was made a priori based loosely on the format of a systematic review, registered in PROSPERO (CRD42017072043), and all post hoc changes to the protocol were appropriately noted. According to the criteria set a priori, eligibility included parallel randomized clinical trials (or meta-analyses thereof) on human patients on any experimental intervention compared to a conventional or control group with any binary/continuous outcome in orthodontics and dentofacial orthopedics. Excluded were non-clinical studies, animal studies, and nonrandomized studies. Split-mouth (within-person) randomized clinical trials were excluded as the suboptimal reporting of such studies in orthodontics makes their integration in meta-epidemiological synthesis difficult [11, 12] . Additionally, only 'hard' outcomes pertaining to overall treatment success, treatment duration, or treatment adverse effects were included, because these can easily be categorized as beneficial/detrimental and are empirically more robust than surrogate outcomes [13] . Ultimately, only meta-analyses of at least three trials, including at least one registered and at least one non-registered trial were included so that meta-epidemiological effects can be estimated. This meta-epidemiological study is loosely conducted and reported according to guidelines for systematic reviews and overviews thereof [1, 7, 14] .
Information sources and literature search
The literature search for this study was done in two steps. Initially data from a recent study [15] that searched the ClinicalTrials.gov and the ISRCTN registries were used to identify all orthodontic subjects with at least one registered randomized trial ( Supplementary Table 1 ). Then, separate literature searches were performed for all identified subjects in order to identify eligible registered or nonregistered randomized trials or systematic reviews with meta-analyses, including at least one randomized trial. A total of six electronic databases (MEDLINE through Pubmed, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Cochrane Database of Abstracts of Reviews of Effects, Web of Knowledge, and Scopus) were searched systematically by one author (SNP) without any limitations from inception up to September 2 nd , 2017 (Supplementary Table 2 ). Four additional sources (Scopus, Google Scholar, ClinicalTrials.gov, and ISRCTN registry) were manually searched for additional M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 trials. No limitations concerning language, publication year or status were applied. All identified relevant systematic reviews with meta-analysis were manually searched for additional trials.
Study selection, data collection, and risk of bias in individual studies
The titles and abstracts of all studies identified by the literature searches were screened by one author (SNP), excluding all those obviously non-relevant according to the study scope and non-clinical studies. The remaining full texts were checked for eligibility by one author (SNP) with a subsequent duplicate independent checking in full by another author (GMX), while conflicts were resolved by the last two authors (MTC, TE). All identified randomized trials were separately checked for eligibility on study design, intervention, and outcome. All meta-analyses included in identified systematic reviews were checked for any eligible randomized trials that could be added to a single meta-analysis without overlap on each topic and outcome to inform the meta-epidemiological synthesis. Trial overlaps within each meta-analysis and across meta-analyses were removed by assigning the Pubmed unique identifier to each trial and including each trial only once per meta-analysis. Where needed, interquartile ranges were converted to standard deviations and similar measurements concerning the same outcome (like visual analogue and Likert pain scales) were combined. When subgroup analyses were performed in identified meta-analyses, these were ignored and the overall pooled estimate was used.
Characteristics of included meta-analysis and trials were extracted fully in duplicate by two authors (SNP, GMX) using pre-determined and piloted extraction forms. Extracted data included first author name, publication year, outcome measured, outcome data, and trial registration status.
Registration status originated from a previous study on two trial registers [15] and was subsequently supplemented by reading the full text of the published paper. Missing data were requested by trialists or calculated from available high-quality graphs with the freely-available Web Plot Digitizer version 3.12 (http://arohatgi.info/WebPlotDigitizer).
The risk of bias of the included randomized trials was not planned to be comprehensively assessed with the Cochrane risk of bias tool [1] , as this was outside the scope of this study. Only the adequacy of the generation of random sequence and blinding of outcome assessor was assessed independently by two authors (SNP, GMX) according to the Cochrane guidelines [1] as low or unclear/high to use this for sensitivity analyses. Differences in risk of bias between registered and non-
registered trials were gauged with cross-tabulation and calculation of relative risks and their 95% Confidence Intervals (CI).
Data synthesis
As the clinical effects of orthodontic trials are bound to be influenced by appliance [16, 17] , patient [18] , or study design-related characteristics [6, 19, 20] a random-effects model was chosen a priori, even though no clear guidance for model choice in meta-epidemiological studies exists. The Paule-Mandel random-effects variance estimator was preferred to the DerSimonian and Laird one, following recent advice [21] .
For all included meta-analyses, the Standardized Mean Difference (SMD) was chosen as the effect measure because it standardizes estimates by their variability and enables overall synthesis [22] . Binary outcomes were planned to be converted to SMDs prior to pooling, but no eligible binary outcomes were identified. All outcomes were categorized as beneficial or harmful and all SMDs were recoded on the same direction, so that a positive SMD was beneficial. When trials with more than one experimental (interventional) trial arms were included, these arms were pooled prior to the meta-analysis to avoid double-counting of control patients.
Random-effects meta-regression with the Paule-Mandel variance estimator was performed, fully incorporating heterogeneity between-trials, to derive a difference in SMDs (ΔSMD) and the standard error within each meta-analysis, according to registration status of included trials. Ultimately, Paule-Mandel random-effects meta-analysis (i.e. meta-epidemiological synthesis) was used to pool the overall effect of trial registration across all component meta-analyses taking into account variability across them.
The magnitude for SMDs and ΔSMD was arbitrarily assessed using Cohen's [22] guidelines: up to 0.2=small effect, 0.2 to 0.5=medium effect, 0.5 to 0.8=large effect, and larger than 0.8=very large effect.
These cut-off values were also adopted to visually enhance the produced forest plot [23] .
Absolute and relative between-meta-analyses heterogeneity/inconsistency was quantified with the tau² metric and the I² statistic, respectively. The latter is defined as the proportion of total variability in the results explained by heterogeneity, and not chance [24] . 95% CIs around all heterogeneity measures were calculated to quantify existing uncertainty [25] , while 95% predictive intervals were to be calculated for the meta-epidemiological synthesis to provide a range of possible effects for a future
clinical setting [26] . All analyses were run in Stata SE 14.0 (StataCorp, College Station, TX) by one author (SNP) and all material was openly made available through Zenodo [27] . A two-tailed P-value of 0.05 was considered significant for hypothesis-testing, except for a 0.10 used for the test of heterogeneity and reporting biases, due to low power [28] .
Additional analyses
Random-effects subgroup analyses were planned a priori to identify possible differences in the effect of trial registration among various orthodontic topics, binary versus continuous outcomes, subjective versus objective outcomes, and positive or negative effect direction with an interaction term by Paule-Mandel meta-regression. Indications of reporting biases (including small-study effects) were assessed with Egger's linear regression test [29] and contour-enhanced funnel plots [30] .
Robustness of the results to possible sources of bias or confounding was planned to be checked in sensitivity analyses by (i) including only meta-analyses with an arbitrary cut-off of at least 10 trials/metaanalysis, (ii) comparing the results of fixed-effect and random-effects models, and (iii) including only the largest meta-analysis from each included Intervention-Control comparison. Additionally, (iv) a post hoc sensitivity analysis by including the 50% of meta-analyses with most included trialswas performed after identifying signs of small-study effects. Finally, (v) a sensitivity analysis was performed to account for different risk of bias for the randomization sequence generation or (vi) for the blinding of outcome measurement across trials by including both trial registration and bias as factors in the within-metaanalysis meta-regression of meta-analyses with at least 5 trials, before pooling the overall effect of trial registration across meta-analyses.
Results
Study selection
The literature search yielded a total of 1241 hits electronically and 18 hits manually as of September 2, 2017; 216 of which, proceeded to full text assessment after eliminating duplicates and ineligible studies by title or abstract (Figure 1 ; Supplementary Table 3a- Table 4 ), which were provided.
Study characteristics
The 16 eligible meta-analyses included a total of 83 trials with overlap (median of 3.5 trials;
interquartile range 3 to 6 trials; range 3 to 14 trials) and a total of 4988 randomized patients (median of 47 patients; interquartile range 30 to 60 patients; range 14 to 1000 patients). Analyzing the characteristics of included trials without overlap, a total of 59 published reports pertaining to 48 unique randomized trials were identified (Supplementary Table 5 ), which randomized a median of 40 patients (interquartile range 30 to 60 patients; range 14 to 1000 patients) to a total of 3188 patients. Among these 48 trials, only 10 of them (20.8%) had been registered in a trial registry overall, with registered trials within each meta-analysis ranging from 10% to 66% (Supplemenary Table 6 ). A wide variety of outcomes were assessed in these trials including treatment duration, dental or skeletal treatment, and adverse effects like patient-reported pain or treatment-induced root resorption.
Risk of bias within studies
Hints of bias (i.e. systematic differences in the results) within included trials was primarily addressed according to their registration status. Additionally, the adequacy of the random sequence generation was formally assessed according to the Cochrane risk of bias tool. From the 48 identified trials, low risk of bias was found for the randomization sequence in 32 trials (66.7%), while the rest of the trials had either unclear or high risk of bias. Adequate blinding of outcome assessment was found for 15 of the 48 (31.3%) identified trials. Registered trials were more likely to have low risk of bias for the randomization generation (90.0% vs 60.5%, respectively; relative risk: 1.49; 95% CI: 1.07 to 2.07) and more likely to have low risk of bias for blinding of outcome assessors (93.3% vs 54.6%; relative risk: 1.38; 95% CI: 0.56 to 3.43).
Results of individual meta-analyses and meta-epidemiological synthesis
The results of all included meta-analyses including the registration status and risk of bias for randomization or blinding of outcome assessor can be seen in full detail in Supplementary Figure The meta-epidemiological synthesis of all 16 included meta-analyses indicated that considerable differences in the reported intervention effects were seen between registered and non-registered trials (pooled ΔSMD: -0.36; 95% CI: -0.60, -0.12; P: 0.003). This indicated that registered trials reported less favorable intervention effects compared to non-registered trials, which could be interpreted as signs of bias. Based on Cohen's classification, this bias would be judged as of moderate magnitude. The observed absolute (tau 2 : 0; 95% CI: 0, 0.18) and relative heterogeneity (I 2 : 0%; 95% CI: 0%, 42%) was minimal and the 95% predictive intervals coincided with the 95% CIs.
Additional analyses
No robust evidence could be found for differences among subgroups according to clinical scenario, outcome scope, nature, or direction (Table 1 ). Although great variation was seen (especially for the different clinical scenarios), very wide 95% CI were observed, indicating imprecision due to break-up of the sample.
As far as reporting biases are concerned, the funnel plot gave clear signs of asymmetry, which were formally confirmed by Egger's test (coefficient=-0.88; 95% CI=-1.59, -0.18; P=0.02). Based on the funnel plot the source of this asymmetry was taken to be small-study effects, with smaller and more imprecise meta-analyses reporting greater ΔSMDs.
A number of pre-defined sensitivity analyses were performed on the main analysis ( Table 2) . Choice of statistical model or choice of only one meta-analysis per clinical scenario was not associated with the observed effects. Due to significant signs of small-study effects an additional post hoc sensitivity analysis with only the 50% largest meta-analyses was performed, which yielded identical ΔSMD.
Additionally, a separate sensitivity analysis controlling for low or unclear/high risk of bias for the generation of the randomization sequence found likewise that the observed effects were robust (ΔSMDs of -0.36 and -0.37 for the original and adjusted analysis, respectively). Finally, a separate sensitivity analysis controlling for low or unclear/high risk of bias for blinding outcome assessment found that trial registration had considerably higher influence on the observed effects (ΔSMDs of -0.36 and -1.80 for the original and adjusted analysis, respectively), but caution is needed as only 3 meta-analyses contributed to this. 
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Discussion
Principal findings
The present review summarizes empirical evidence up to September 2017 about the effects of trial registration on the results of orthodontic randomized clinical trials. Empirical evidence from 16 meta-analyses and 4 988 patients indicated that registered trials report considerably less beneficial treatment effects compared to non-registered trials, which can be interpreted as signs of bias of moderate magnitude. The fact that bias from lack of registration was found to be of moderate magnitude must not be underestimated, since this source of bias can act in an additive manner together with other known bias-related sources, such as, inadequate randomization or baseline imbalance, lack of blinding, small sample size, choice of control group, and others [19, [31] [32] [33] [34] [35] [36] .
Comparison with other studies
To our knowledge this is the first study to provide statistically significant empirical evidence of bias from lack of trial registration in an oral health field. The only study similar to ours is the comprehensive meta-epidemiological study from Dechartres et al. [8] , who assessed Cochrane Reviews with binary outcomes published between 2011 and 2014. Although they included a greater number of meta-analyses (n=37) across various medical fields, they found a small effect indicating that nonregistered trials tended to show larger treatment effect estimates than registered trials (ratio of odds ratios=0.85; 95% CI=0.67-1.08), which was not statistically significant. Differences with our results could be explained by the inclusion in the Dechartres et al. [8] study of more heterogeneous trial outcomes than the present study, where only 'hard' outcomes were included. Additionally, Dechartres et al. [8] found similar magnitude of bias for non-registered versus registered trials (ratio of odds ratios of 0.85)although not statistically significant. Another cross-sectional overview of randomized trials found only a weak association between trial registration and positive study results (adjusted risk ratio of 0.87) and a possible variation between non-industry and industry funded trials [10] , but concluded that evidence is inconsistent. However, it must be noted that this was a large unselected group of randomized trials across various research question and unstratified by disease, intervention, and outcome and therefore, a potentially existing effect might have been masked by the pooled analysis. 
Strengths and limitations
Strengths of the current study include the a priori development of a research protocol that was precisely followed and the detailed reporting of all post hoc choices (Appendix), which supports the study's credibility [37] . Additionally, maximized data output through author communications, use of an improved variance estimator [21] , graphical assessment of the effects' clinical relevance with contours of magnitude [38] , and transparent open data provision [27] can be counted among the study's strengths.
This study also has some limitations. First, it was based on a convenience sample limited to a dental specialty field, which meant that only a small number of eligible trials could eventually be included and that the meta-epidemiological synthesis might be potentially underpowered. Therefore, additional empirical evidence is needed to confirm or refute the findings of the current study. Second, as only studies from a single field were included, the studies results might not directly transferable to other field, although no rationale for this exists. Third, trial registration might be associated with many other trial characteristics possibly linked to bias like geographic origin, number of study centers, sample size and used methods, which was not considered in this study. Finally, we did not differentiate between randomized trials having been prospectively or retrospectively registered and we did not directly assess firsthand discrepancies between the trials' published reports and protocols. These were not planned during protocol and it would not be possible to formally integrate those factors in the analysis, due to the already limited existing material. This can be the focus of future empirical studies with a wider scope.
Conclusions and policy implications
It is evident from the results of this study that trial registration, apart from being crucial to the transparency and credibility of a trial, can potentially influence either directly or indirectly the current evidence base and therefore clinical recommendations. Our findings support the the initiatives of the World Health Organization, the International Committee of Medical Journal Editors towards, and other research regulatory authorities to provide a depository for trial registration and to promote policies that support trial registration and adherence to reporting guidelines. The current situation of clinical trials in orthodontics suboptimal both in terms of registration [15] and reporting quality [39] . Efforts have been made from orthodontic journals to improve author adherence to the Consolidated Standards of Reporting Trials (CONSORT) guidelines [40] . However and even though a large part of medical journals requires all M A N U S C R I P T
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submitted trials to be registered [41] , only five out of the ten existing orthodontic journals only mention trial registration in their author instructions, while only one (Journal of Orthodontics) words this explicitly as a requirement for publication [15] . It is important finally to note that trial registration does not preclude the use of inappropriate methods or bias.
Summary
The present meta-epidemiological study provides empirical evidence of bias originating from a lack of protocol registration among randomized clinical trials in orthodontics and dentofacial orthopaedics. Therefore, caution is warranted by the interpretation of unregistered trials or by their incorporation in systematic reviews and clinical guidelines. However, the evidence base that was used in the present study is limited and future studies are expected to expand upon it. Negative is favorable intervention effect 12 -0.29 (-0.59,-0.00) 0.40 Positive is favorable intervention effect 4 -0.49 (-0.90,-0.07) Abbreviations: ∆SMD, difference in standardized mean differences; CI, confidence interval. a this pertains to initial direction of outcome. Outcomes were uniformly transformed on the same direction to pool. * for between-subgroup differences.
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Analysis
Meta-analyses ∆SMD (95% CI) P 3 -1.80 (-3.54,-0.06) 0.04 Abbreviations: ∆SMD, difference in standardized mean differences; CI, confidence interval. a Only meta-analyses with ≥5 trials were included in this. Both registration status and low (or unclear/high) risk of bias for random sequence generation were used within each meta-analysis to calculate ∆SMDs, which were afterwards pooled across meta-analyses. b Only meta-analyses with outcomes that could be blinded were included. Both registration status and low (or unclear/high) risk of bias for blind outcome measurement were used within each meta-analysis to calculate ∆SMDs, which were afterwards pooled across meta-analyses.
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